Sign In
Buy NVTA
$0.0190
+0 (+0%)
At Close: May 13, 2024
Invitae CEO on the opportunity and competition in genetic testing
03:45pm, Friday, 12'th Mar 2021
Ark Invest's Cathie Wood called genetic testing firm Invitae an underappreciated stock last week in a CNBC interview. Sean George, Invitae CEO, joins 'Closing Bell' to discuss the company's mission, t
Why Invitae Stock Jumped Today
03:15pm, Thursday, 11'th Mar 2021
The company unveiled its inaugural ESG report. But the overall rise in growth stocks was its main catalyst.
Invitae Releases Inaugural Environmental, Social and Governance (ESG) Report
07:30am, Thursday, 11'th Mar 2021
SAN FRANCISCO, March 11, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the issuance of its inaugural Environmental, Social and Governance (
Cathie Wood says Invitae is an under-appreciated stock
04:14pm, Monday, 08'th Mar 2021
Cathie Wood, ARK Invest CEO, says one of the most under-appreciated stocks is Invitae, a company which offers medical genetic testing. She joins 'Closing Bell' to discuss.
Why Invitae Stock Tumbled Again Today
03:53pm, Thursday, 04'th Mar 2021
The overall market sell-off dragged Invitae's shares down.
Should You Buy Invitae Stock?
06:26am, Thursday, 04'th Mar 2021
The past 12 months have been a wild ride for the genetic testing company's stock, with a sub-$10 low and a high of more than $60.
Why Invitae Stock Fell Today
03:24pm, Wednesday, 03'rd Mar 2021
The medical genetics company was pulled down by a broader sell-off of growth stocks.
Invitae adds Medneon's risk assessment tools to its education and clinical support offerings
07:30am, Wednesday, 24'th Feb 2021
SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the addition of tools from Medneon, a digital health AI company, to i
Why Invitae Stock Is Falling Today
01:23pm, Tuesday, 23'rd Feb 2021
The healthcare company is diving along with the market.
Invitae Outlook Remains Positive Even After Continuing Losses, Dilution
11:24am, Tuesday, 23'rd Feb 2021
Invitae is a genetic testing company that aims to deliver packages of medical information to consumers—by the billions. It enjoys reasonable financial strength but has been consistently unprofitable
Why Invitae Stock Fell 11.1% Today
04:52pm, Monday, 22'nd Feb 2021
There's nothing to be alarmed about.
Seagate, Micron, Invitae and More Thursday Afternoon Analyst Calls
02:21pm, Thursday, 18'th Feb 2021
With the trading day more than halfway over, the broad markets were trading lower with the Dow down about 0.4 while the S&P 500 traded down about 0.5% and Nasdaq traded down nearly 0.9%.
Why Veru, Invitae And More Are Moving Today
11:52am, Thursday, 18'th Feb 2021
Community Health Systems (NYSE: CYH) shares are trading higher after the company reported better-than-expected fourth-quarter sales results. Community Health Systems is the largest publicly owned hosp
Why Invitae's Q4 Results Didn't Fire Up Investors
06:05am, Thursday, 18'th Feb 2021
The company's revenue soared, but so did its expenses.
Invitae Corporation (NVTA) CEO Sean George on Q4 2020 Results - Earnings Call Transcript
08:52pm, Wednesday, 17'th Feb 2021
Invitae Corporation (NVTA) CEO Sean George on Q4 2020 Results - Earnings Call Transcript
